Aligos Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALGS and other ETFs, options, and stocks.About ALGS
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of therapeutics for chronic liver diseases and viral infections. The firm is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses, as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH).
CEOLawrence M. Blatt
CEOLawrence M. Blatt
Employees70
Employees70
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2018
Founded2018
Employees70
Employees70
ALGS Key Statistics
Market cap60.74M
Market cap60.74M
Price-Earnings ratio-0.44
Price-Earnings ratio-0.44
Dividend yield—
Dividend yield—
Average volume69.44K
Average volume69.44K
High today$8.60
High today$8.60
Low today$8.60
Low today$8.60
Open price$8.60
Open price$8.60
Volume852.00
Volume852.00
52 Week high$35.30
52 Week high$35.30
52 Week low$3.76
52 Week low$3.76
Stock Snapshot
As of today, Aligos Therapeutics(ALGS) shares are valued at $8.60. The company's market cap stands at 60.74M, with a P/E ratio of -0.44.
During the trading session on 2026-01-13, Aligos Therapeutics(ALGS) shares reached a daily high of $8.60 and a low of $8.60. At a current price of $8.60, the stock is 0.0% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 852, compared to an average daily volume of 69.44K.
Over the past 52 weeks, Aligos Therapeutics(ALGS) stock has traded between a high of $35.30 and a low of $3.76.
Over the past 52 weeks, Aligos Therapeutics(ALGS) stock has traded between a high of $35.30 and a low of $3.76.
People also own
Based on the portfolios of people who own ALGS. This list is generated using Robinhood data, and it’s not a recommendation.